CytoSorbents(CTSO) - 2018 Q4 - Earnings Call Presentation

CytoSorbents Corporation (NASDAQ: CTSO) A Leader in Critical Care Immunotherapy Q4 2018 and Full Year 2018 Earnings Conference Call March 7, 2019 Conference Call Participants Vincent Capponi, MS Chief Operating Officer Kathleen Bloch, MBA, CPA Chief Financial Officer Dr. Eric Mortensen, MD, PhD Chief Medical Officer Dr. Christian Steiner, MD Vice President of Sales and Marketing 2 Dr. Phillip Chan, MD, PhD Chief Executive Officer and President Chris Cramer, MS, MBA Vice President of Business Development Mod ...